Can renovascular hypertension present in infancy and be missed by renal artery Doppler ultrasound and computed tomography (CT) renal angiography, and what further workup should be pursued?

Renovascular Hypertension in Infancy: Diagnostic Limitations and Further Workup

Yes, renovascular hypertension can absolutely present in infancy and be missed by both renal artery Doppler ultrasound and CT angiography—particularly when disease involves small intrarenal segmental or subsegmental vessels, accessory renal arteries, or when technical factors limit visualization in infants.

Why Standard Imaging Can Miss Renovascular Disease in Infants

The critical limitation is that both Doppler ultrasound and CT angiography may fail to adequately resolve small intrarenal vessels, which are frequently the culprit in renovascular hypertension of infancy 1. A pediatric study demonstrated that ultrasound has only 63% sensitivity (though 95% specificity), while CT angiography achieved 88% sensitivity and 81% specificity 2. These are unacceptably low sensitivities when clinical suspicion is high, as 22% of renovascular disease cases were missed by non-invasive imaging in this cohort 2.

Specific Reasons for False Negatives:

• Intrarenal small vessel disease: Segmental and subsegmental branch stenoses are below the resolution threshold of non-invasive modalities 3
• Accessory renal arteries: Frequently undetected by Doppler ultrasound 1
• Technical limitations in infants: Small vessel size, patient body habitus, obscuring bowel gas, and inability to cooperate with breath-holding 4, 1
• Disease distribution: 16% of pediatric renovascular disease involves intrarenal small vessels that are inherently difficult to visualize 2

Recommended Further Workup Algorithm

Step 1: ACE Inhibitor Renography (Captopril Renal Scintigraphy)

This should be your next diagnostic step 1. Using intravenous enalaprilat, this functional imaging detects hemodynamically significant renovascular disease with approximately 90% sensitivity and specificity 1. This test identifies functionally significant stenosis even when anatomic imaging is negative.

Key advantages:

• Detects functional impact of stenosis regardless of vessel size
• Can be performed regardless of renal function status
• Does not require contrast or sedation

Step 2: Digital Subtraction Angiography (DSA)

If clinical suspicion remains high despite negative non-invasive imaging, proceed directly to formal catheter angiography 2. This is the definitive recommendation because:

• DSA remains the gold standard for diagnosing renovascular disease in children 2, 3
• Non-invasive imaging cannot reliably rule out renovascular disease when clinical and laboratory criteria are highly suggestive 2
• In the pediatric series, DSA diagnosed renovascular disease in 78% of referred children, with 80% undergoing successful percutaneous transluminal angioplasty during the same procedure 2

The ACR Appropriateness Criteria rate conventional arteriography as "usually not appropriate" (rating 3) for initial screening 4, but this applies to adult populations with normal renal function. In infants with high clinical suspicion and negative non-invasive studies, the paradigm shifts—DSA becomes both diagnostic and potentially therapeutic 2, 3.

Clinical Indicators That Should Prompt Aggressive Workup

Proceed with further investigation when you see:

• Severe or malignant hypertension in an infant
• Hypertension presenting with cardiogenic shock 5
• Prompt blood pressure response to ACE inhibitors (suggests renin-mediated hypertension) 5
• Elevated plasma renin levels 6, 7
• Refractory hypertension despite multiple medications
• Asymmetric kidney size or function on initial ultrasound

Important Caveats

Timing of Intervention

Even when renovascular disease is confirmed in young infants, medical management should be prioritized until the child is large enough to undergo angiography and angioplasty successfully 1. The vessels may be too small for safe intervention in early infancy.

MRA Limitations

While MRA without contrast is rated as "usually appropriate" in adults with decreased renal function 4, MRA may not adequately resolve small intrarenal vessels in infants 1. Don't rely on MRA alone in this population.

The "Bystander" Stenosis Problem

Remember that anatomic stenosis doesn't always equal hemodynamically significant renovascular hypertension 6. This is why functional imaging (ACE inhibitor renography) or therapeutic response (blood pressure improvement after intervention) are critical confirmatory steps 4.

Bottom Line Algorithm for Infants

1. Initial screening: Renal ultrasound with Doppler (already done, negative in your case)
2. Anatomic confirmation attempt: CT angiography (already done, negative in your case)
3. Functional assessment: ACE inhibitor renography with IV enalaprilat
4. Definitive diagnosis: If clinical suspicion remains high (severe hypertension, elevated renin, ACE inhibitor responsiveness), proceed to formal catheter angiography regardless of negative non-invasive studies
5. Management: Medical control until infant is large enough for safe endovascular intervention

The key principle: In infants with strong clinical suspicion of renovascular hypertension, negative non-invasive imaging does not exclude the diagnosis 2. The sensitivity gaps are too large to rely on these modalities alone when dealing with potentially curable hypertension that threatens long-term cardiovascular and renal outcomes.